CClinicalTrials.gg
CompletedNCT06829667Updated Sep 1, 2026

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

An observational study in Lateral Ankle Instability, sponsored by Stryker Trauma and Extremities. Completed at 4 sites in United States. Open to participants aged 14 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Stryker Trauma and Extremities · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
103
Ages
14 Years to 75 Years
Sex
All
01

Study summary

This study is intended to be a retrospective chart review of patients with chronic ankle instability who have undergone a lateral ligament reconstructive procedure for ATFL repair (isolated or non-isolated) with suture tape augmentation. Patients that have been treated at any of the participating institutions that have undergone an ATFL reconstruction with Arthrex InternalBrace augmentation who have postoperative hospital or ASC records of safety and effectiveness as measured by adverse events, potential complications, and potential functional outcomes past the 10-week time point will be included.

02

Conditions studied

  • Lateral Ankle Instability

Keywords

  • ATFL reconstructive procedure
03

In context

Lead sponsor

Stryker Trauma and Extremities is the lead sponsor of 43 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Approximately 75 subjects underwent an ATFL repair with Arthrex InternalBrace

Inclusion criteria

  • Patients between and including the age of 14-75 at the time of surgery
  • Patients who were diagnosed with lateral ankle instability by physician clinical assessment
  • Patients who underwent an ATFL repair with Arthrex InternalBrace augmentation device (does not require an isolated repair)

Exclusion criteria

Exclusion Criteria:

  • Significant secondary procedures done at the time of repair, including significant osteochondral lesions and/or significant microfracture of the talus or tibia that warrant modifying the typical lateral ligament repair post-op rehab protocol. (Minor microfractures and OCD lesions that do not warrant bone debridements, synovectomies, and bone spur removals are allowed)
  • Any concomitant orthopedic procedure that will extend the post-op rehabilitation (e.g., casting/immobilization) beyond the routinely prescribed rehab protocol following an ATFL reconstructive procedure.
  • Patients undergoing a Calcaneal osteotomy
  • Patients with less than 6 weeks follow-up
  • Patients with incomplete medical records
  • Patients with Worker's Compensation Cases
  • Any patient with a history of infection of the ankle predating the ankle repair
  • Any orthopedic issue outside of the ankle that the Investigator feels may impede functional endpoint outcome measures.
  • Patients who have a medical history that would likely make the patient an unreliable research participant
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
103 participants (actual)
Patient registry
No

Interventions

  • DeviceArthrex InternalBrace

    Arthrex InternalBrace is composed of a polyethylene/polyester suture tape and knotless bone anchors to provide ligament repair bridging and reinforce ligament strength. There have been conflicting results surrounding the clinical efficacy of its use in lateral ligament reconstruction.

06

What researchers measure

Primary outcomes

  1. Evaluate Effectiveness

    The overall objective of this study is to evaluate the effectiveness and safety of suture tape when used as an augmentation device during surgical reconstruction of ATFL in patients suffering lateral ankle instability. The assessment of effectiveness will be measured by the rate of complications as defined by those patients that necessitated a return to the OR, including implant failure, symptomatic implant requiring removal, peri-implant fracture, deep wound infection and foreign body reaction.

    Time frame: 12 weeks to last recorded follow-up

  2. Evaluate Safety

    The overall objective of this study is to evaluate the effectiveness and safety of suture tape when used as an augmentation device during surgical reconstruction of ATFL in patients suffering lateral ankle instability. Safety of study subjects will be established by recording treatment, incidence and frequency of adverse events. Also, adverse events will be classified as procedure related and/or product related.

    Time frame: 2 weeks to last recorded follow-up

07

Study locations

4 sites
  • MORE Foundation
    Phoenix, Arizona 85023, United States
  • KUMC
    Kansas City, Kansas 66103, United States
  • Seaview Orthopaedics
    Ocean City, New Jersey 07712, United States
  • ERLANGER
    Chattanooga, Tennessee 37403, United States
08

References and documents

Individual participant data

Plan to share: No — Unknown at this time

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06829667
Lead sponsor
Stryker Trauma and Extremities
Responsible party
Sponsor
First posted
Feb 17, 2025
Start date
Oct 13, 2023
Primary completion
Apr 8, 2026
Completion
Apr 8, 2026
Last update
Sep 1, 2026

Study contacts

Rebecca Gibson
study director · Stryker Trauma & Extremities

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion